Raheel Zubair is a Dermatology physician affiliated with Cosmetic Laser Dermatology. OpenAlex indexes 35 publications with 405 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AVITA MedicalProgram year20252 paymentsResearch$13,500openpaymentsdata.cms.gov ↗
- PfizerProgram year20252 paymentsResearch$13,399openpaymentsdata.cms.gov ↗
- IncyteProgram year20252 paymentsResearch$11,000openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
45.8%Azole Antifungal45.8%Ketoconazole100%Part D≥22 patientsDermatology
34.9%Corticosteroid19.3%Triamcinolone Acetonide100%Part D≥13 patientsAllylamine Antifungal15.7%Terbinafine Hcl100%Part D≥13 patientsSensory organs
19.3%Corticosteroid19.3%Clobetasol Propionate100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Comprehensive Review of Dermal Fillers and Biostimulators for Neck Rejuvenation
Dermatologic Surgery
2026 - Autologous cell harvesting device provides repigmentation and improves quality-of-life for patients with stable vitiligo lesions in a large and diverse patient population
Journal of the American Academy of Dermatology
2025 - Safety and Efficacy of Photodynamic Therapy with Aminolevulinic Acid 10% Topical Gel Activated by Red Light versus Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for the Treatment of Actinic Keratosis on the Upper Extremities: A Blinded Randomized Study
SKIN The Journal of Cutaneous Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Sabrina Fabi, MD
Cosmetic Laser Dermatology
Kimberly Butterwick, MD
Cosmetic Laser Dermatology
Douglas C. Wu
Cosmetic Laser Dermatology
Erick Mafong, MD
Cosmetic Laser Dermatology
Robert Modlin, MD
University of California, Los Angeles
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Joel Gelfand, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”